Cargando…
Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 Carbapenemase in Qatar
The objective of our study was to describe the molecular support of carbapenem resistance from randomly selected clinical isolates of multidrug-resistant (MDR) Acinetobacter baumannii as a pilot study from the Hamad Medical Corporation (HMC), Qatar. Results of our report will be used to study carbap...
Autores principales: | Rolain, J.-M., Loucif, L., Al-Maslamani, M., Elmagboul, E., Al-Ansari, N., Taj-Aldeen, S., Shaukat, A., Ahmedullah, H., Hamed, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802191/ https://www.ncbi.nlm.nih.gov/pubmed/27054039 http://dx.doi.org/10.1016/j.nmni.2016.02.006 |
Ejemplares similares
-
Multidrug-Resistant Acinetobacter baumannii Harboring OXA-24 Carbapenemase, Spain
por: Acosta, Joshi, et al.
Publicado: (2011) -
Carbapenemase OXA-423: A Novel OXA-23 Variant in Acinetobacter baumannii
por: Yang, Zhenghai, et al.
Publicado: (2020) -
Worldwide Dissemination of the bla(OXA-23) Carbapenemase Gene of Acinetobacter baumannii(1)
por: Mugnier, Pauline D., et al.
Publicado: (2010) -
Diversity of carbapenem-resistant Acinetobacter baumannii and bacteriophage-mediated spread of the Oxa23 carbapenemase
por: Abouelfetouh, Alaa, et al.
Publicado: (2022) -
Identification of OXA-23 carbapenemases: novel variant OXA-239 in
Acinetobacter baumannii ST758 clinical isolates in Mexico
por: Tamayo-Legorreta, E M, et al.
Publicado: (2014)